HAVCR2 and neoplasm: Anti–TIM-3 treatment of KB1P tumor-bearing mice (but not other checkpoint inhibitors) increased Vγ4+ cell numbers when compared with control-treated mice, while anti–PD-1 treatment (but not other checkpoint inhibitors) increased Vγ6+ cell numbers when compared with control (Fig. 7 C).